The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: AssesSment of Early deteCtion basEd oN liquiD Biopsy in Intracranial Tumors
Official Title: Assessment of Early Detection Based on Liquid Biopsy in Intracranial Tumors: a Prospective Observational Study
Study ID: NCT05679089
Brief Summary: ASCEND-BRAIN is a prospective, observational study aimed at early-detection of intracranial tumors by combined assays of cfDNA methylation and other biomarkers. The study will enroll approximately 358 participants including intracranial malignant tumors, patients with benign disorders of central nervous system and healthy participants.
Detailed Description:
Minimum Age: 40 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: Yes
Zhujiang Hospital, Guangzhou, Guangdong, China
Name: Hongbo Guo, MD,Ph.D
Affiliation: Zhujiang Hospital
Role: PRINCIPAL_INVESTIGATOR